Health experts urge greater gender balance in clinical trials

Eur Activ: March 8, 2013

Too few women are taking part in clinical tests to develop new drugs, putting their lives at risk as women’s bodies react differently to medicines, health experts said ahead of International Women’s Day.

Cardiovascular disease causes 40% of all deaths in the EU but has traditionally been regarded as a male disease, keeping women largely out of clinical trials to develop new drugs.

Yet cardiovascular disease is also the leading cause of death among women and this one-size-fits-all approach is putting women’s health at risk, according to experts.

Marco Stramba-Badiale, director of the Department of Geriatrics and Cardiovascular Medicine at IRCCS Istituto Auxologico Italiano in Milan, said regulatory agencies should adopt strict rules on the inclusion of women in clinical trials and a systematic gender analysis. Read more